Fresh analysis indicates that individuals who discontinue popular slimming jabs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who halt traditional diet and exercise programs.
Research printed in a leading medical journal demonstrates that while obese people can lose about a fifth of their body weight while on the medication, the weight comes back at an estimated rate of nearly a kilo each month once they quit.
"Users purchasing these medications should be aware of the potential of rapid weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.
This pace of regain means a reversion to original mass within about one and a half years.
Comparing Therapies
The study, which looked at dozens of studies involving thousands of patients, contrasted the results of GLP-1 agonists with older methods.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone typically have a slower creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Rapid Regain
Doctors propose the way of the drugs accounts for the amplified rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone levels far above than normal could lead to the body to produce less of its endogenous hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication results in appetite is unsuppressed, making binge eating a significant risk."
A Chronic Condition?
Health authorities suggest the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, given the significant potential of relapse, the therapy is often life-long.
This perspective is supported by pharmaceutical companies, who note that the results "emphasize the long-term nature of obesity," comparing it to managing conditions like hypertension.
Patient Experiences
People who have come off the medication explain a sudden return of hunger.
"It felt as if something activating and you're instantly ravenous," described an individual.
The struggle is exacerbated if patients have not developed permanent dietary or behavioural changes during treatment.
Growing Interest
Figures suggest that a significant number of adults in the UK have used these injections in the last 12 months, with demand being substantial.
- Use is more common among females compared to men.
- The middle-aged age group shows the highest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
Ultimately, researchers stress that while these medications are potent tools for shedding pounds, they are not a magic fix and maintained weight loss hinges on combined behavioural support.
